India offers advanced and affordable treatment for Hodgkin’s and Non-Hodgkin’s lymphoma, backed by cutting-edge oncology and globally trained experts like Dr. Ankur Bahl. The total treatment cost in India generally ranges from $3,500 to $10,000, depending on the type, stage, and therapy used. In contrast, treatment in the USA costs $40,000–$70,000, and in Thailand around $18,000–$25,000. India delivers cost savings of over 75%, without compromising care quality or outcomes.
Lymphoma is a type of blood cancer that originates in the lymphatic system, which is part of the immune system. It primarily affects lymphocytes, a type of white blood cell that helps fight infection.
The lymphatic system includes the lymph nodes, spleen, bone marrow, and thymus.
Lymphoma can start almost anywhere and may spread quickly or grow slowly depending on the subtype.
Globally, lymphoma accounts for 3–4% of all cancers, and treatment success rates are very high, especially with early diagnosis.
Lymphoma is broadly classified into two main categories:
More common (over 85% of cases).
Includes multiple subtypes:
India offers comprehensive and modern diagnostics for lymphoma:
India follows internationally accepted treatment guidelines (e.g., NCCN, ESMO).
Based on PET-CT scan and bone marrow findings
Hodgkin Lymphoma (Stage I–II)
ABVD regimen: Adriamycin, Bleomycin, Vinblastine, Dacarbazine
4–6 cycles + radiation for bulky disease
India's top cancer centers use advanced tools such as:
Component |
Estimated Cost (USD) |
Consultation + Blood Tests |
$300 – $500 |
PET-CT Scan |
$600 – $1,000 |
Biopsy + IHC |
$500 – $900 |
Chemotherapy (per cycle) |
$300 – $600 |
Immunotherapy (e.g., Rituximab) |
$1,000 – $2,500 |
Hospital Stay (per chemo cycle) |
$400 – $800 |
Bone Marrow Transplant (if done) |
$12,000 – $18,000 |
Total Estimate (6 cycles avg) |
$3,500 – $10,000 |
Country |
Total Cost Estimate |
India |
$3,500 – $10,000 |
Thailand |
$18,000 – $25,000 |
USA |
$40,000 – $70,000 |
India provides world-class treatment with comparable outcomes at a fraction of the cost.
India stands out as a hub for advanced yet affordable lymphoma treatment. With expert oncologists like Dr. Ankur Bahl, world-class hospitals, and comprehensive patient support, international patients can expect top-quality care, smooth coordination, and long-term outcomes. Whether you're seeking cutting-edge chemotherapy, stem cell transplant, or follow-up care, India provides a holistic, cost-efficient, and compassionate approach to beating lymphoma.
Yes, lymphoma is highly curable, especially when diagnosed early and treated appropriately. Hodgkin’s lymphoma (HL), in particular, has a remission rate of over 90% in early stages when treated with standard chemotherapy (ABVD regimen) and, in some cases, radiation therapy. Even aggressive Non-Hodgkin’s lymphomas (NHL) like Diffuse Large B-Cell Lymphoma (DLBCL) can be cured in many patients using intensive chemotherapy regimens like R-CHOP or EPOCH. Long-term survival rates for lymphoma have significantly improved due to advances in chemotherapy, targeted therapies, and stem cell transplantation.
Yes, international patients can undergo autologous (self) and allogeneic (donor) stem cell or bone marrow transplants in India. The procedure is performed in dedicated transplant units equipped with HEPA filters, sterile environments, and round-the-clock critical care. Hospitals in India follow internationally recognized protocols and have success rates comparable to top Western centers. Pre-transplant evaluations, donor matching (for allogeneic transplants), and post-transplant care are managed by experienced hematologists and transplant physicians.